Completed NA INTERVENTIONAL 2-arm NCT00614406

The Effects of a Prostaglandin Inhibitor on Ovulation and the Menstrual Cycle

The Effects of a Prostaglandin Inhibitor on Ovulation and the Menstrual Cycle.

Sponsor: Oregon Health and Science University

Conditions Gonadotropin and Ovarian Hormone Levels (FSH, LH, E2, P) Menstrual Cycles (Total Length, Bleeding Days) Ovulation (Follicular Rupture Yes/no)

Interventions Celebrex Placebo

Updated 8 times since 2017 Last updated: Dec 11, 2012 Started: Jan 31, 2008 Primary completion: Aug 31, 2008 Completion: Aug 31, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Gonadotropin and Ovarian Hormone Levels (FSH, LH, E2, P) and Menstrual Cycles (Total Length, Bleeding Days) and is currently completed. Oregon Health and Science University leads this study, which shows 8 recorded versions since 2008 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2023 — Jul 2024 [monthly]

Completed NA
Dec 2022 — Jan 2023 [monthly]

Completed NA
Jan 2021 — Dec 2022 [monthly]

Completed NA

▶ Show 3 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed NA
Feb 2017 — Jun 2018 [monthly]

Completed NA
Jan 2017 — Feb 2017 [monthly]

Completed NA

First recorded

Jan 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Oregon Health and Science University
Society of Family Planning

Data source: Oregon Health and Science University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Portland, United States